Form 483

Baxter Healthcare Corporation Form 483, 2018-10-24

FDA issued a Form 483 to Baxter Healthcare Corporation on 2018-10-24 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Baxter Healthcare Corporation · Guayama, United States · Issued October 24, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

24 Oct 2018
21 CFR 211.188(b)(5)

In-process and laboratory control results

Cited by Jose F Velez

24 Oct 2018
21 CFR 211.188(b)(5)

In-process and laboratory control results

Cited by Jose F Velez

24 Oct 2018
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Jose F Velez

24 Oct 2018
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Jose F Velez

Inspected site

BHBaxter Healthcare CorporationGuayama, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.188(b)(5)Cited across public-safe Form 483 observations2x
21 CFR 211.58Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere